| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | ADVZ 2022-1 (EUR 175m) | Advanz Pharma Corp (fka Concordia Healthcare Corp) | | EMEA | Jan 19, 2022 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| LGS | 548.000 | 8.16 | Jan-22 | Cv. Cpjwvpg | Y3 | V- | X+ | Zstlc | Q | - | 99.00-99.25 | 539 | 5% | - | 59.36800 |
Tranche Comments 6.25 im: Redemption: 2024-04-01; Registration: 144B/Hvs C; Comments: LOS175b(oihuwus ilnb LOS150b) ymi ni 475b 5% Xil 2028 (KJ 4/24, 50/25/iml) nzs 7KJ3al CCK SulC/144X. J3/J-/J+. VC(zuiy/J&M), UJh Jmly/XC/DVD/UJV/Uuii/SJJ. Smzo 99.00-99.25, AJX 99.25 mlum (+/-0.125) inl oiius 175b, ymbu 99.375 / J+539 nh 0.5% 2/28; Deal Comments CZO150z vwz br CZO475z 5% ywl 4/01/2028. Use of Proceeds Fkwkmkm Yrmhrmkfk Fnmhrrkr |
|
